![]() ![]() But the odds of surviving with less disability were 27 percent greater for patients treated with alteplase. The effect of alteplase on disability was, thus, not statistically significant. For every 1,000 patients treated within 6 hours, 14 more were alive and independent. ![]() At 6 months, 554 (37 percent) patients in the alteplase group met the primary end point (ie, were alive and independent) compared with 534 (35 percent) of those in the control group (OR 1♱3, 95% CI 0♹5-1♳5, P=0♱81). This multicenter, randomized, open treatment trial assessed 3,035 patients (1,515 receiving alteplase and 1,520 in a control group) at 156 hospitals in 12 countries of these 53 percent were older than 80 years. In one, the third International Stroke Trial (IST-3), researchers determined whether all patients with stroke, irrespective of age, benefited from treatment with the thrombolytic agent alteplase, a recombinant plasminogen activator (rt-PA), when given up to 6 hours following stroke onset. Ll patients with stroke, regardless of age, should receive thrombolysis according to findings from two studies. Thrombolysis benefits elderly stroke patients Rajesh Kumar NEWS Common antibiotic for acute undifferentiated feverĢ009 H1N1 flu pandemic deadlier than reported INDONESIA FOCUS Pentingnya nutrisi lengkap pada ibu hamil Thrombolysis benefits elderly stroke patients ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |